A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis

Critical Care Medicine

Volumn 37, Issue 1, 2009, Pages 96-104

  Shapiro, Nathan I ^a   Trzeciak, Stephen ^c   Hollander, Judd E ^d   Birkhahn, Robert ^e   Otero, Ronny ^f   Osborn, Tiffany M ^h   Moretti, Eugene ^j   Nguyen, H Bryant ^k   Gunnerson, Kyle J ^l   Milzman, David ^m   Gaieski, David F ^d   Goyal, Munish ^d   Cairns, Charles B ⁱ   Ngo, Long ^b   Rivers, Emanuel P ^f,g  

^a Division of General Medicine   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Department of Anesthesiology   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e NEW YORK METHODIST HOSPITAL   (United States)

^f Department of Surgery ^*  (United States)

^g HENRY FORD HEALTH SYSTEM   (United States)

^h UNIVERSITY OF VIRGINIA   (United States)

ⁱ DUKE UNIVERSITY   (United States)

^j Division of Pulmonary   (United States)

^k LOMA LINDA UNIVERSITY   (United States)

^l University Reanimation   (United States)

^m WASHINGTON HOSPITAL CENTER   (United States)

more..

Author keywords

Biomarker; Infection; Mortality; Organ dysfunction; Risk assessment; Sepsis

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LACTIC ACID; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEIN C; ACUTE PHASE PROTEIN; INTERLEUKIN 1; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; GROUPS BY AGE; HOSPITALIZATION; HUMAN; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNIVERSITY HOSPITAL; BLOOD; CLINICAL TRIAL; EMERGENCY HEALTH SERVICE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PREDICTION AND FORECASTING; RISK ASSESSMENT; SEPSIS;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITAL MORTALITY; HUMANS; INTERLEUKIN-1; LIPOCALINS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN C; PROTO-ONCOGENE PROTEINS; RISK ASSESSMENT; SEPSIS; SHOCK, SEPTIC;

EID: 59649123701     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318192fd9d     Document Type: Article

References (32)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
2. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871
3. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
4. Dellinger RP, Carlet JM, Masur H, et al: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873
5. Kumar A, Roberts D, Wood KE, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596
6. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
7. Abraham E, Laterre PF, Garg R, et al: Dro-trecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005; 353:1332-1341
8. Shapiro N, Howell MD, Bates DW, et al: The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 2006; 48:583-590
9. Regnault V, Levy B: Recombinant activated protein C in sepsis: Endothelium protection or endothelium therapy? Crit Care 2007; 11: 103
10. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
11. Buechler KF: Near-patient tests: The Triage® system. In: The Immunoassay Handbook Wild D (Ed). Oxford, Elsevier, 2005, pp 424-430
12. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256
13. Akaike H: Information theory as an extension of the maximum likelihood principle. Second International Symposium on Information Theory. Akademiai Kiado 1974; 267-281
14. Dinarello C: The proinflammatoory cyto-kines interleukin-1 and tumor necrosis factor and the treatment of septic shock syndrome. J Infect Dis 1991; 163:1177-1184
15. Kuster H, Weiss M, Willeitner AE, et al: Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 1998; 352:1271-1277
16. Marie C, Muret J, Fitting C, et al: Interleukin-1 receptor antagonist production during infectious and noninfectious systemic inflammatory response syndrome. Crit Care Med 2000; 28:2277-2282
17. Gogos CA, Drosou E, Bassaris HP, et al: Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options. J Infect Dis 2000; 181:176-180
18. van Deuren M, van der Ven-Jongekrijg J, Bartelink AK, et al: Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 1995; 172:433-439
19. Rivers EP, Kruse JA, Jacobsen G, et al: The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007; 35: 2016-2024
20. Osuchowski MF, Welch K, Siddiqui J, et al: Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006; 177:1967-1974
21. Esmon CT: The protein C pathway. Chest 2003; 124(Suppl 3):26S-32S
22. Fisher CJ Jr, Yan SB: Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 2000; 28(Suppl 9):S49-S56
23. Shorr AF, Bernard GR, Dhainaut JF, et al: Protein C concentrations in severe sepsis: An early directional change in plasma levels predicts outcome. Crit Care 2006; 10:R92
24. Macias WL, Nelson DR: Severe protein C deficiency predicts early death in severe sepsis. Crit Care Med 2004; 32(Suppl 5):S223-S228
25. Kjeldsen L, Johnsen AH, Sengelov H, et al: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993; 268: 10425-10432
26. Faure E, Thomas L, Xu H, et al: Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: Role of NF-kappa B activation. J Immunol 2001; 166:2018-2024
27. Mishra J, Ma Q, Prada A, et al: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14:2534-2543
28. Devarajan P: Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17:1503-1520
29. Mishra J, Dent C, Tarabishi R, et al: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365:1231-1238
30. Bozza FA, Salluh JI, Japiassu AM, et al: Cytokine profiles as markers of disease severity in sepsis: A multiplex analysis. Crit Care 2007; 11:R49
31. Kofoed K, Andersen O, Kronborg G, et al: Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: A prospective study. Crit Care 2007; 11:R38
32. Jones AE, Fitch MT, Kline JA: Operational performance of validated physiologic scoring systems for predicting in-hospital mortality among critically ill emergency department patients. Crit Care Med 2005; 33:974-978